Sandeep Singhania ☀️

[𝗪𝗲𝗹𝗹𝗻𝗲𝘀𝘀 𝗖𝗵𝗲𝗺𝗶𝘀𝘁 @GodswillChemist]

Magnesium for you needs.

[Sandeep Singhania ☀️ @Sandep_80]

@AshokShrivasta6 Both are not same

[𝐊𝐫𝐢𝐬𝐡𝐧𝐚𝐩𝐫𝐞𝐞𝐭𝐢 @Krishnavallabhi]

The secret to deeper meditation is literally in your hands.

These 5 ancient hand mudras can help calm your mind, improve focus, and deepen your meditation practice.

Practice them for just 5 minutes a day and experience the difference.

🧵👇

[🇮🇳 Focused Investing @ParveenBhansali]

#KrishanaPhoschem

Most powerful growth triggers from their latest Q1FY27 Concall 👇🏻

Most Powerful Growth Triggers Ahead

- Sharp utilization ramp in Q2 - Raw material availability has normalized and management expects significantly higher NPK-DAP capacity utilization from Q2 onwards.

- Full benefit of expanded NPK capacity - Capacity has increased from 3.3 lakh MT to 4.95 lakh MT, providing a strong runway for volume and revenue growth.

- Management targets 30-35% FY27 revenue growth with ₹500+ crore quarterly revenue expected over the remaining three quarters.

- Better product mix - Newly launched high value NPK grades are improving realizations and supporting structurally stronger EBITDA margins.

- Backward integration advantage - In house sulphuric and phosphoric acid operations provide a cost edge over peers, especially during periods of raw material inflation.

- Favourable monsoon recovery - Improved rainfall and accelerated Kharif sowing should support fertilizer demand through the upcoming seasons.

- Healthy margin outlook - Management expects margins to remain healthy as higher capacity utilization offsets increased depreciation and finance costs.

- Future green ammonia sourcing - The 10 year SECI agreement positions the company for a structural raw material cost advantage from FY29, strengthening the long term investment case.

- ⚠️Operating cash flows positive only in FY25 out of last 5 financial years.

- ⚠️Debt Equity Ratio reasonably very high @ 1.3

[Nikhil Jha @NIKHILLJHA]

🚨Health Insurance- How much coverage is enough?

India's medical inflation is at a staggering 14%
The cost of treatment is doubling every 5 years

How much cover is enough?🤔🤔
🩺5L
🩺10L
🩺25L
Can u enhance your cover with a super top-up?

A thread🧵on how much cover u should have & how to build it?👇

[🇮🇳 Focused Investing @ParveenBhansali]

#SyrmaSGS
Key Growth Drivers for FY27-28 🚀

- Management confidence is rising: The tone has shifted from simply "achieving" guidance to "exceeding" it. Management believes FY27 growth can surpass the 35%+ revenue guidance, provided geopolitical disruptions remain under control.

- Strong execution visibility: Around ₹5,400 crore of the ₹6,770 crore order book is scheduled for execution over the next 12 months, providing excellent revenue visibility.

- Exports remain a major growth engine: Management expects 30-40% export growth in FY27, with exports carrying a superior margin profile and increasing integration into global supply chains.

- ODM scaling up: The high margin Own Design Manufacturing (ODM) business continues to expand, improving both profitability and customer stickiness.

- Healthcare momentum: A ₹500 crore healthcare order book and management's expectation of 50% growth in the MedTech business make healthcare one of the fastest growing verticals.

- Defence recovery: Management expects the defence business to strengthen progressively over the coming quarters as new technologies and product offerings are added.

- Automotive electrification: Rising demand for EV electronics and charging infrastructure continues to drive strong growth in the automotive segment.

- New technology opportunities: Development of server motherboard manufacturing with select customers opens up a new avenue to participate in AI and data centre infrastructure.

- RFID solutions gaining traction: The RFID business continues to scale, supported by increasing adoption across industries.

- Water purification electronics: This vertical is witnessing healthy demand and is emerging as another growth contributor.

- Telecom recovery: The telecom business is showing signs of revival, adding another layer to the company's diversified growth profile.

- Future revenue pipeline: The company onboarded 18 new customers during Q1. While these programs will ramp up over the next 12-30 months, management believes they represent a ₹1,000+ crore long term revenue opportunity.

Why FY27 Could Be a Re-rating Year
- Strong execution backed by a large executable order book.

- High margin exports and ODM becoming a larger share of revenue.

- Multiple verticals - Healthcare, EV, Defence and Telecom growing simultaneously.

- Management publicly indicating confidence in exceeding, not just meeting, FY27 guidance.

- A healthy pipeline of new customers creating visibility well beyond FY27.

[Sandeep Singhania ☀️ @Sandep_80]

@NIKHILLJHA Superr

[Sandeep Singhania ☀️ @Sandep_80]

@DietDrsayajirao Remedy and treatment for high TSH

[Dr Prashant Mishra @drprashantmish6]

When it comes to the reservation system, everyone goes silent—whether it’s the CJp, BJP, Congress, or AAP. The careers of millions of hardworking students are ruined because of caste-based reservations. Now, everyone claims to want a fair education system, yet they still insist on keeping reservation.

[Aadi Achint 🇮🇳 @AadiAchint]

Damn this guy. Hats off.

[Sandeep Singhania ☀️ @Sandep_80]

@darvasboxtrader Which one

[Sandeep Singhania ☀️ @Sandep_80]

@Rishikesh_ADX 🙏 Om Shanti 🙏

[Nitin R @finallynitin]

🚨 Presenting the Strong Start RVOL Dashboard TradingView indicator, free for everyone!

Paste a watchlist → it ranks every name by RVOL & stars the ones that have a strong start

- Credits to @FreeThinkEd for the original script on which this is based
- Credits to @imanasarora for the strong start concept

[Sandeep Singhania ☀️ @Sandep_80]

@BSNL_BIHAR Sim active rekhna hai, plan details bataye

[STOCK TIGERS @hjyadav]

📈 Learn how to select stocks for Intraday & Swing Trading in the actual live market.

✅ Stock Selection
✅ Price Action
✅ Volume Analysis
✅ Live Market Examples

🎥 Watch Now:
https://t.co/lDCWOFApDw

#IntradayTrading #SwingTrading #StockMarket #LiveMarket

[Sandeep Singhania ☀️ @Sandep_80]

@Anirbban Take care

[Dr SHRADDHEY KATIYAR @Wegiveyouhealt1]

HOW TO
RECOGNIZE DEFICIENCIES IN THE BODY:

COLD HANDS AND FEET
Constantly cold extremities can point to low iron or an underactive thyroid driven by an iodine deficiency, since both are needed to carry oxygen and generate body heat.

HAIR LOSS AND THINNING
Hair shedding is one of the first signs of low iron, low zinc, or inadequate protein, because your body deprioritizes hair growth the moment resources run short.

CRACKS AT THE CORNERS OF YOUR MOUTH
Splitting or sores at the corners of your mouth often signal a deficiency in B vitamins, especially B2 and B6, along with iron.

MUSCLE CRAMPS AND TWITCHES
Random cramping, twitching eyelids, or charley horses usually point to low magnesium, potassium, or calcium

RIDGED OR SPOONED
FINGERNAILS
Vertical ridges, brittleness, or nails that curve upward like a spoon are classic indicators of an iron deficiency.

TINGLING IN YOUR HANDS AND FEET
Numbness or a pins-and-needles feeling in your extremities can be an early warning sign of low B12, which your nerves depend on to function.

BUMPY SKIN ON THE BACKS OF YOUR ARMS
Those small rough bumps, often mistaken for normal skin texture, can reflect a deficiency in vitamin A or essential fatty acids.

A-SWOLLEN OR SCALLOPED
TONGUE
A tongue that looks beefy and red or has wavy indentations along the edges can point to low B12, folate, or iron.

YOUR BODY IS ALWAYS TALKING
Your body is constantly giving you clues, and these surface-level signs are often the first place a deeper deficiency shows up.
Pay attention to what it is telling you and get the right things tested.

[Sandeep Singhania ☀️ @Sandep_80]

@JioCare Please launch a validity plan for incoming purpose and sim active

[Sandeep Singhania ☀️ @Sandep_80]

@multibaggerwala I think speed, xtra premium is pure